Home -> Law Blog Directory -> Patent Law Blogs -> Patent Docs
(866) 635-2689 for Personal Injury or (866) 635-9402 for Criminal Defense
Find a Local Lawyer
Divorce (866) 635-6190
Personal Injury (866) 635-2689
Criminal Defense (866) 635-9402
Patent Law
: Patent DocsObviousness-type Double Patenting after Amgen v. F. Hoffmann-La Roche
By Donald Zuhn, Kevin Noonan, Chris Singer, Sherri Oslick, and Jason Derry
Full post as published by Patent Docs on September 28, 2009 (boomark / email).
CellCept
Roche Issues Changes to Warnings and Adverse Events
Type 2 Diabetes
Linked to Arsenic in Water
Digitek Recalled
the heart drug allegedly contains double the medication that it should
Personal Property Taxes
Village of Romeo pays Ford Motor Company a $1.2 million settlement for double charging.
Rutland School District
Double pay offered as part of class action wage dispute settlement, pending court approval.
Cipro
The FDA is seeking to add black box warnings of the risk of tendon rupture associated with Cipro and Levaquin.
The ruptures can involve Achilles tendon, shoulder, hand, bicep or thumb tendons, and is especially increased in patients older than 60, or people who have received kidney, heart or lung transplants, as well as people on steroid therapy...

A Divisional Patent Application By Any Other Name Is Not A Divisional
Ending the Doctrine of Non-Statutory Double Patenting
Is being pro-active a good thing
Amgen whips Roche in Mircera case; injunction granted
Federal Circuit Addresses Effect of 271(e)(1) "Safe Harbor" in ITC Actions
Fed. Cir.: Section 121 "Safe Harbor" Provision Does Not Apply to Continuations








